Introduction
Splanchnic vein thrombosis (SVT) represents an occlusion within veins draining the abdominal organs, a condition increasingly diagnosed in cancer patients, especially those with intra-abdominal malignancies such as pancreatic cancer. Advances in oncological care and routine imaging have contributed to higher detection rates of SVT in this population. Despite its rising prevalence, the long-term clinical outcomes of cancer-associated SVT and the value of anticoagulant treatment remain poorly understood. This article synthesizes evidence from a recent retrospective observational study examining outcomes at one-year follow-up to clarify these aspects.
